Oliver Bartsch

Oliver Bartsch

Auto-generated profile, based on publicly available information

Oliver Bartsch

Medical Care Centre Section Human Genetics and Institute of Human Genetics, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany

Research Focus & Metrics

Representative Publications

View All Publications
14 July 2005 in Human Genetics
Verified
Journal Article
Closed access
PDF file
OBOliver Bartsch
Oliver Bartsch
SSStefanie Schmidt
Stefanie Schmidt
MRMarion Richter
Marion Richter
SMSusanne Morlot
Susanne Morlot
ESEva Seemanová
Eva Seemanová
SRSasan Rasi
Sasan Rasi

14 February 2007 in European Journal of Human Genetics
Verified
Journal Article
Closed access
NZNicole Zimmermann
Nicole Zimmermann
AAAna Maria Bravo Ferrer Acosta
Ana Maria Bravo Ferrer Acosta
JKJürgen Kohlhase
Jürgen Kohlhase
OBOliver Bartsch
Oliver Bartsch

23 December 2009 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
OBOliver Bartsch
Oliver Bartsch
JLJanette Labonté
Janette Labonté
BABeate Albrecht
Beate Albrecht
DWDagmar Wieczorek
Dagmar Wieczorek
SLStanislav Lechno
Stanislav Lechno
THThomas Haaf
Thomas Haaf

17 June 2006 in Human Genetics
Verified
Journal Article
Closed access
PDF file
OBOliver Bartsch
Oliver Bartsch
SRSasan Rasi
Sasan Rasi
ADAlicia Delicado
Alicia Delicado
SDSarah Dyack
Sarah Dyack
LNLuitgard M. Neumann
Luitgard M. Neumann
VKVera Kalscheuer
Vera Kalscheuer

3 August 2005 in European Journal of Human Genetics
Verified
Journal Article
Open access
OBOliver Bartsch
Oliver Bartsch
ALAnne Loitzsch
Anne Loitzsch
PKPeter Kozlowski
Peter Kozlowski
MMMarie-Luise Mazauric
Marie-Luise Mazauric
GHGabriele Hickmann
Gabriele Hickmann
Fluorescence in situ hybridization (FISH) analyses were performed on supernumerary marker chromosomes (SMCs) detected in 43,273 prenatal diagnoses over a period of 11 years, 1993-2003. A total of 42 pregnancies with SMC were identified, indicating a prevalence of one in 1032. A total of 15 SMCs were endowed with detectable euchromatin (prevalence, 1/2884), including six SMCs containing the cat eye critical region (CECR) on chromosome 22q11.21 (1/7212). De novo SMCs were found in 29 pregnancies (1/1492), including 14 euchromatic SMCs (48.2%). Follow-up studies were available for 24 cases. Nine pregnancies (37.5%) were terminated; two children (8.3%) were born with Pallister-Killian syndrome and cat eye syndrome (CES), respectively; 13 children (54.1%) showed apparently normal development. Familial SMCs were identified in 13 pregnancies (1/3328) from 11 unrelated women. They were all acrocentric. In all, 10 were heterochromatic and one was an extra der(22)t(11;22) chromosome. A total of 12 cases were available for follow-up. One pregnancy was terminated due to anhydramnios, spina bifida, and cystic-dysplastic kidneys; one child suffered from a der(22) syndrome; 10 children (83.3%) appeared unaffected. Studies for uniparental disomy were performed on seven pregnancies and revealed a case of maternal heterodisomy for chromosome 22. So far this is the largest FISH study of prenatally ascertained SMCs and the first study with detailed data on the prevalence. Findings illustrate the spectrum and clinical outcomes of prenatally diagnosed SMCs, and indicate a higher frequency of SMCs than generally assumed.

1 July 2016 in Ear & Hearing
Verified
Journal Article
Open access
BVBarbara Vona
Barbara Vona
SLStanislav Lechno
Stanislav Lechno
MHMichaela A. H. Hofrichter
Michaela A. H. Hofrichter
SHSusanne Hopf
Susanne Hopf
ALAnne K. Läßig
Anne K. Läßig
OBOliver Bartsch
Oliver Bartsch
Objective: PDZD7 was identified in 2009 in a family with apparent nonsyndromic sensorineural hearing loss. However, subsequent clinical reports have associated PDZD7 with digenic Usher syndrome, the most common cause of deaf-blindness, or as a modifier of retinal disease. No further reports have validated this gene for nonsyndromic hearing loss, intuitively calling correct genotype–phenotype association into question. This report describes a validating second case for biallelic mutations in PDZD7 causing nonsyndromic mild to severe sensorineural hearing loss. It also provides detailed audiometric and ophthalmologic data excluding Usher syndrome in both the present proband (proband 1) and the first proband described in 2009 (proband 2). Design: Proband 1 was sequenced using a custom-designed next generation sequencing panel consisting of 151 deafness genes. Bioinformatics analysis and filtering disclosed two PDZD7 sequence variants (c.1648C>T, p.Q550* and c.2107del, p.S703Vfs*20). Segregation testing followed in the family. For both probands, audiograms were collected and analyzed for progressive hearing loss and detailed ophthalmic evaluations were performed including electroretinography. Results: Proband 1 demonstrated a prelingual, nonsyndromic, sensorineural hearing loss that progressed in the higher frequencies between 4 and 9 years old. PDZD7 segregation analysis confirmed biallelic inheritance (compound heterozygosity). Mutation analysis determined the c.1648C>T mutation as novel and reported the c.2107del deletion as rs397516633 with a calculated minor allele frequency of 0.000018. Clinical evaluation spanning well over a decade in proband 2 disclosed bilateral, nonprogressive hearing loss. Both probands showed healthy retinas, excluding Usher syndrome-like changes in the eye. Conclusions: PDZD7 is confirmed as a bona fide autosomal recessive nonsyndromic hearing loss gene. In both probands, there was no evidence of impaired vision or ophthalmic pathology. As the current understanding of PDZD7 mutations bridge Mendelian and complex phenotypes, the authors recommend careful variant interpretation, since PDZD7 is one of many genes associated with both Usher syndrome and autosomal recessive nonsyndromic hearing loss. Additional reports are required for understanding the complete phenotypic spectrum of this gene, including the possibility of high-frequency progression, as well as noise-induced hearing loss susceptibility in adult carriers. This report rules out all forms of Usher syndrome with an onset before 12 and 15 years old in probands 1 and 2, respectively. However, due to the young ages of the probands, this report is uninformative regarding older patients.